0.0050
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 64.27M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PRIME MOVERS LAB FUND I LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.67 - 1.88 per share. | Indirect | 168,588 | Sep 8, 2023 |
| DIAMANDIS PETER Director | Conversion of Exercise of derivative security at price 0.57 - 1.21 per share. | Direct | 300,816 | Apr 26, 2023 |
Related Tickers
BO1.MU BioCryst Pharmaceuticals Inc
7.62
-0.57%
ISI.SG Ionis Pharmaceuticals Inc
31.90
+1.11%
CMVLF Cellectis S.A.
1.2500
0.00%
LTI.SG Aptose Biosciences Inc
0.1580
+1.28%
PMRA.F Pharma Mar, S.A.
84.70
-1.63%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
SLGL Sol-Gel Technologies Ltd.
0.7151
-7.12%
NBYB.SG Northwest Biotherapeutics, Inc.
0.2560
+3.23%
BXRXQ Baudax Bio, Inc.
0.0000
-99.00%
OTLC Oncotelic Therapeutics, Inc.
0.0280
0.00%